Meeting
2021 ASCO Annual Meeting
A large real-world study on the effectiveness of the combined inhibition of EGFR and MET in EGFR-mutant advanced non-small cell lung cancer (NSCLC).
Authors
Liu Li
Hunan Cancer Hospital, Changsha, China
Liu Li , Jingjing Qu , Jianfu Heng , Chunhua Zhou , Yi Xiong , Haiyan Yang , Wenjuan Jiang , Liang Zeng , Songlin Zhu , Yongchang Zhang , Jiarong Tan , Ting Hou , Analyn Lizaso , Zhiqiu Chen , Chengping Hu , Pengbo Deng , Nong Yang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9043)
DOI
10.1200/JCO.2021.39.15_suppl.9043
Abstract #
9043
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody
Poster
2015 ASCO Annual Meeting
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).
First Author: Shingo Matsumoto
Poster
2014 ASCO Annual Meeting
A phase II cluster study of single agent AUY922, BYL719, INC280, LDK378, and MEK162 in Chinese patients with advanced non-small cell lung cancer (NSCLC).
First Author: Qing Zhou